6.
Musen M, OConnor M, Schultes E, Martinez-Romero M, Hardi J, Graybeal J
. Modeling community standards for metadata as templates makes data FAIR. Sci Data. 2022; 9(1):696.
PMC: 9653497.
DOI: 10.1038/s41597-022-01815-3.
View
7.
Olsson A, Guha N, Bouaoun L, Kromhout H, Peters S, Siemiatycki J
. Occupational Exposure to Polycyclic Aromatic Hydrocarbons and Lung Cancer Risk: Results from a Pooled Analysis of Case-Control Studies (SYNERGY). Cancer Epidemiol Biomarkers Prev. 2022; 31(7):1433-1441.
PMC: 9377765.
DOI: 10.1158/1055-9965.EPI-21-1428.
View
8.
Manrai A, Cui Y, Bushel P, Hall M, Karakitsios S, Mattingly C
. Informatics and Data Analytics to Support Exposome-Based Discovery for Public Health. Annu Rev Public Health. 2017; 38:279-294.
PMC: 5774331.
DOI: 10.1146/annurev-publhealth-082516-012737.
View
9.
van der Velde K, Imhann F, Charbon B, Pang C, van Enckevort D, Slofstra M
. MOLGENIS research: advanced bioinformatics data software for non-bioinformaticians. Bioinformatics. 2018; 35(6):1076-1078.
PMC: 6419911.
DOI: 10.1093/bioinformatics/bty742.
View
10.
Yang J, Yu D, White E, Lee D, Blot W, Robien K
. Prediagnosis Leisure-Time Physical Activity and Lung Cancer Survival: A Pooled Analysis of 11 Cohorts. JNCI Cancer Spectr. 2022; 6(2).
PMC: 8962711.
DOI: 10.1093/jncics/pkac009.
View
11.
Wolfson M, Wallace S, Masca N, Rowe G, Sheehan N, Ferretti V
. DataSHIELD: resolving a conflict in contemporary bioscience--performing a pooled analysis of individual-level data without sharing the data. Int J Epidemiol. 2010; 39(5):1372-82.
PMC: 2972441.
DOI: 10.1093/ije/dyq111.
View
12.
Turner M, Nieuwenhuijsen M, Anderson K, Balshaw D, Cui Y, Dunton G
. Assessing the Exposome with External Measures: Commentary on the State of the Science and Research Recommendations. Annu Rev Public Health. 2017; 38:215-239.
PMC: 7161939.
DOI: 10.1146/annurev-publhealth-082516-012802.
View
13.
Vermeulen R, Schymanski E, Barabasi A, Miller G
. The exposome and health: Where chemistry meets biology. Science. 2020; 367(6476):392-396.
PMC: 7227413.
DOI: 10.1126/science.aay3164.
View
14.
Torkzadehmahani R, Nasirigerdeh R, Blumenthal D, Kacprowski T, List M, Matschinske J
. Privacy-Preserving Artificial Intelligence Techniques in Biomedicine. Methods Inf Med. 2022; 61(S 01):e12-e27.
PMC: 9246509.
DOI: 10.1055/s-0041-1740630.
View
15.
Juarez P, Hood D, Song M, Ramesh A
. Use of an Exposome Approach to Understand the Effects of Exposures From the Natural, Built, and Social Environments on Cardio-Vascular Disease Onset, Progression, and Outcomes. Front Public Health. 2020; 8:379.
PMC: 7437454.
DOI: 10.3389/fpubh.2020.00379.
View
16.
Maitre L, Guimbaud J, Warembourg C, Guil-Oumrait N, Petrone P, Chadeau-Hyam M
. State-of-the-art methods for exposure-health studies: Results from the exposome data challenge event. Environ Int. 2022; 168:107422.
DOI: 10.1016/j.envint.2022.107422.
View
17.
Visweswaran S, Becich M, DItri V, Sendro E, MacFadden D, Anderson N
. Accrual to Clinical Trials (ACT): A Clinical and Translational Science Award Consortium Network. JAMIA Open. 2018; 1(2):147-152.
PMC: 6241502.
DOI: 10.1093/jamiaopen/ooy033.
View
18.
Johnson C, Athersuch T, Collman G, Dhungana S, Grant D, Jones D
. Yale school of public health symposium on lifetime exposures and human health: the exposome; summary and future reflections. Hum Genomics. 2017; 11(1):32.
PMC: 5723043.
DOI: 10.1186/s40246-017-0128-0.
View
19.
Vrijheid M, Slama R, Robinson O, Chatzi L, Coen M, van den Hazel P
. The human early-life exposome (HELIX): project rationale and design. Environ Health Perspect. 2014; 122(6):535-44.
PMC: 4048258.
DOI: 10.1289/ehp.1307204.
View
20.
Martin-Sanchez F, Bellazzi R, Casella V, Dixon W, Lopez-Campos G, Peek N
. Progress in Characterizing the Human Exposome: a Key Step for Precision Medicine. Yearb Med Inform. 2020; 29(1):115-120.
PMC: 7442499.
DOI: 10.1055/s-0040-1701975.
View